3.8 Article

Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Children With Cystic Fibrosis Have Elevated Levels of Fecal Chitinase-3-like-1

Jessica Permain et al.

Summary: Fecal levels of CHI3L1 were higher in children with CF compared to healthy controls, without correlation to growth parameters or pancreatic insufficiency, indicating potential gut inflammation in CF patients that requires further investigation to confirm and determine long-term implications.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2022)

Review Gastroenterology & Hepatology

Understanding the development and function of the gut microbiota in health and inflammation

Deepak Selvakumar et al.

Summary: The gut microbiota has a symbiotic relationship with the host and plays an important role in maintaining gut health. Altered gut microbiota is common in gastrointestinal diseases, but the causal relationship with disease pathogenesis is poorly understood. NEC and IBD are severe inflammatory diseases affecting the gastrointestinal tract, and both demonstrate dysbiosis of gut microbiota and dysregulated host immune response. By comparing changes in gut microbiota and host immune response, common features in clinically unrelated diseases can be identified.

FRONTLINE GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Dan Turner et al.

Summary: STRIDE-II presents treatment targets for both adult and pediatric IBD, including long-term and short-term goals. These targets cover aspects such as clinical response, endoscopic healing, quality of life, and growth, providing guidance for improving patient outcomes.

GASTROENTEROLOGY (2021)

Article Pediatrics

Faecal calprotectin levels during the first year of life in healthy children

Burcu Sena Gunaydin Sahin et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2020)

Review Pathology

An update on diagnostic and prognostic biomarkers in inflammatory bowel disease

Andrew S. Day et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)

Review Gastroenterology & Hepatology

Fecal biomarkers in inflammatory bowel disease

Robert N. Lopez et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Normative Fecal Calprotectin Concentrations in Guatemalan Preschoolers Are High Relative to Children Reported Elsewhere

Maria-Jose Soto-Mendez et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)

Article Respiratory System

YKL-40 as marker of severe lung disease in cystic fibrosis patients

Salvatore Leonardi et al.

JOURNAL OF CYSTIC FIBROSIS (2016)

Review Gastroenterology & Hepatology

Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases

Jason Orlando Dimitri Musci et al.

JOURNAL OF GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma

Floris A. E. De Voogd et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Review Gastroenterology & Hepatology

Fecal calprotectin in inflammatory bowel disease

Natalie E. Walsham et al.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

Arie Levine et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)

Review Pediatrics

Fecal biomarkers of intestinal health and disease in children

Tamara Pang et al.

FRONTIERS IN PEDIATRICS (2014)

Article Biotechnology & Applied Microbiology

Fecal S100A12 in Healthy Infants and Children

A. S. Day et al.

DISEASE MARKERS (2013)

Article Gastroenterology & Hepatology

Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12

Jan Daebritz et al.

INFLAMMATORY BOWEL DISEASES (2013)

Article Gastroenterology & Hepatology

European evidence based consensus for endoscopy in inflammatory bowel disease

Vito Annese et al.

JOURNAL OF CROHNS & COLITIS (2013)

Article Gastroenterology & Hepatology

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

Ren Mao et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Gastroenterology & Hepatology

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Geert D'Haens et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Gastroenterology & Hepatology

Crohn's and colitis in children and adolescents

Andrew S. Day et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Article Gastroenterology & Hepatology

Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease

T. Aomatsu et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)

Article Gastroenterology & Hepatology

Osteoprotegerin in Pediatric Crohn's Disease and the Effects of Exclusive Enteral Nutrition

Lily Nahidi et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Gastroenterology & Hepatology

Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon

Michael Dam Jensen et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Development and Assessment of a Modified Pediatric Crohn Disease Activity Index

Steven T. Leach et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2010)

Editorial Material Gastroenterology & Hepatology

Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells

Katrin Eurich et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Improved Diagnosis of Colorectal Cancer Using a Combination of Fecal Occult Blood and Novel Fecal Protein Markers

Johann Karl et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

S1225 Fecal Osteoprotegerin: A Marker for Pediatric Ulcerative Colitis At Diagnosis - a Pilot Study

Anthony Skinner et al.

GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

Marca A. Sidler et al.

INFLAMMATORY BOWEL DISEASES (2008)

Article Gastroenterology & Hepatology

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

M Daperno et al.

GASTROINTESTINAL ENDOSCOPY (2004)

Article Gastroenterology & Hepatology

Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease

I Vind et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)

Letter Gastroenterology & Hepatology

Age-dependent variations in fecal calprotectin concentrations in children

J Rugtveit et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)